Clinical Trial: A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553299) titled 'A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities' on April 02.

Brief Summary: The purpose of this study is to identify the weekly oral dose of VRB-101 (oral ecnoglutide) that can effectively maintain body weight in participants with a history of obesity or overweight with weight-related comorbidities.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Obesity Overweight Weight Maintenance

Intervention: DRUG: VRB-101

VRB-101 tablets will be administered orally.

DRUG: Placebo

Placebo tablets will be admi...